As per research about pharmaceutical As per research about pharmaceutical industries, The Indian industries, The Indian pharma marketpharma market is 3rd is 3rd largest in terms of volume and 13th largest in largest in terms of volume and 13th largest in terms of value.terms of value.

Continuous technological advancement and Continuous technological advancement and exclusive cost-effective strategies, the Indian exclusive cost-effective strategies, the Indian pharma industry has grabbed a good space in pharma industry has grabbed a good space in the export stream.the export stream.

The Indian pharmaceutical business is The Indian pharmaceutical business is estimated to grow at twenty per cent compound estimated to grow at twenty per cent compound annual growth over the forthcoming 5 years.annual growth over the forthcoming 5 years.

The pharmaceutical industries are rapidly The pharmaceutical industries are rapidly growing in India and worldwide market.growing in India and worldwide market.

The domestic drug company rate was 11.9% in The domestic drug company rate was 11.9% in last year October 2014. highlighted the report.last year October 2014. highlighted the report.

http://www.ibef.org/industry/pharmaceutical-india.aspx

There are many There are many bulk drugs manufacturersbulk drugs manufacturers and and exporters in India and worldwide. The Indian bulk exporters in India and worldwide. The Indian bulk drugs manufacturer and exporters are becoming drugs manufacturer and exporters are becoming global leaders in niche areas.global leaders in niche areas.

With a large share in the 40% worldwide bulk drug With a large share in the 40% worldwide bulk drug production, India the 2production, India the 2ndnd biggest bulk drug exporter, biggest bulk drug exporter, has now declared that the winner countrys bulk has now declared that the winner countrys bulk drugs that cost very short are not incentive any drugs that cost very short are not incentive any more for the manufacturers back in India.more for the manufacturers back in India.

The Indian Bulk Drug business is predicted to The Indian Bulk Drug business is predicted to grow at a CAGR of twenty first to succeed in grow at a CAGR of twenty first to succeed in US$16.91 billion by 2013-14 as per this study.US$16.91 billion by 2013-14 as per this study.

India has the number of Drug Master Filings India has the number of Drug Master Filings (DMF) amongst all key competitive economies.(DMF) amongst all key competitive economies.

The world knows how popular China and India The world knows how popular China and India are in manufacturing bulk drugs after being are in manufacturing bulk drugs after being popularly known for highly populated countries popularly known for highly populated countries in the world.in the world.

In view of the numerous growth potential of the In view of the numerous growth potential of the Indian bulk medicine trade, Cygnus releases Indian bulk medicine trade, Cygnus releases the most recent version of the Indian Bulk the most recent version of the Indian Bulk medicine trade Insight.medicine trade Insight.

Source: SFDA Southern Medicine Economic Institute

There are many There are many generic drugs suppliersgeneric drugs suppliers in India in India and global markets.and global markets.

Generic drugs are completely safe and perfect Generic drugs are completely safe and perfect substitute for plenty of drugs. They are also substitute for plenty of drugs. They are also approved by FDA team and already have approved by FDA team and already have undergone various clinical trials to prove safety. undergone various clinical trials to prove safety. To know more on generic drugs, you should To know more on generic drugs, you should discuss with suppliers promptly.discuss with suppliers promptly.

The pharma market in India is unique in that it is The pharma market in India is unique in that it is dominated by branded generics which enjoy a dominated by branded generics which enjoy a value premium although they're not optimal to value premium although they're not optimal to unbranded generics in either therapeutic price unbranded generics in either therapeutic price or pharmacopoeia. Marketing of branded or pharmacopoeia. Marketing of branded generics has led to higher costs, irrational fixed generics has led to higher costs, irrational fixed dose concentration as well as combinations in dose concentration as well as combinations in the pharmaceutical industry. it's time Asian nation the pharmaceutical industry. it's time Asian nation moved towards a de-branding of generic moved towards a de-branding of generic medication.medication.

Yash Complex,167,Kamal Park Society,Yash Complex,167,Kamal Park Society,B/h Kapodra fire Station,Varachha Road,Surat-394211,(Gujarat), INDIAB/h Kapodra fire Station,Varachha Road,Surat-394211,(Gujarat), INDIAEmail:info@actizapharma.comEmail:info@actizapharma.comPhone:+91 261 2572050Phone:+91 261 2572050

Slide 1Slide 2Slide 4Slide 5Slide 6Slide 7Slide 8Slide 9Slide 10Slide 11Slide 12